AAHRPP Accredits Four More Research Organizations
WASHINGTON, D.C.âThe Association for the Accreditation of Human Research Protection Programs today announced that it has accredited four more research organizations-one each in the U.S., Canada, Korea, and Taiwan.
The newly accredited organizations are:
- BC Diabetes, Vancouver, British Columbia, Canada
- Boston Medical Center and Boston University Medical Campus, Boston, Massachusetts
- Chang Gung Medical Foundation, Taipei City, Taiwan
- Korea University Medical Center, Seoul, Korea
They join 18 other organizations in earning AAHRPP accreditation this year, bringing the total to 22 in 2017 and 251 accredited organizations overall. Of those, 49 are outside the U.S.
“This was a good year for AAHRPP accreditation and for the research participants that AAHRPP’s high standards help protect,” AAHRPP President and CEO Elyse I. Summers said.
“AAHRPP accreditation has long been recognized as the gold standard for research protections and as evidence of an organization’s commitment to high-quality, ethical research,” she added. “In an increasingly collaborative research enterprise, accreditation is more valuable than ever because it signals that an organization is a trusted partner.”
To earn accreditation, organizations must show that they have built extensive safeguards into every level of their research operation and that they adhere to high standards for research.
AAHRPP has accredited organizations across the United States and in Belgium, Brazil, Canada, China, India, Mexico, Republic of Korea, Saudi Arabia, Singapore, South Africa, Taiwan and Thailand.
All major U.S. independent institutional review boards have earned AAHRPP accreditation. In addition, 70 percent of U.S. medical colleges and 84 percent of the top National Institute of Health-funded academic medical centers are either AAHRPP accredited or have begun the accreditation process. NIH, the world’s largest public funder of research, has earned accreditation, as has Pfizer, Inc., the largest industry sponsor of clinical research.
About AAHRPP:
A nonprofit organization, AAHRPP provides accreditation for organizations that conduct or review human research and can demonstrate that their protections exceed the safeguards required by the U.S. government. To learn more, visit www.aahrpp.org.
###
FOR MORE INFORMATION CONTACT:
Sarah Kiskaddon
Vice President, Global Development and Public Affairs
skiskaddon@aahrpp.org
(202) 783-1112
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
